等待開盤 09-20 09:30:00 美东时间
+1.960
+4.92%
As of Sept. 19, 2024, three stocks in the consumer staples sector could be flas...
09-19 20:37
有投资者在深交所互动平台向安科生物提问:"公司参股博生吉多少股份?免疫细胞未来市场巨大,对公司会有哪些积极影响?"公司回复称:"您好,公司紧随国际生物技术发展步...
09-18 15:52
Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Seeking Alpha's earnings calendar for a full list of companies due to report....
09-14 03:00
Cantor Fitzgerald initiated coverage of 22 stocks in its global internet sector, pulling out several names as a Top Pick as the firm weights the brewing risks at the macro/micro level against accelera...
09-06 02:48
国泰君安预计,科济药业-B(02171)2024年赛恺泽商业化订单对应终端市场销售额将达1亿元,对应87份订单(115万/人)。
09-04 09:05
Adding Cleveland Clinic, UC Davis, And Sutter Health; MSKCC Remains Lead Site, With Ex-U.S. Data Showing 92% Response Rate
08-28 21:33
21世纪经济报道记者季媛媛 见习记者闫硕 上海、北京报道 8月27日,传奇生物宣布,公司自主研发的细胞治疗产品卡卫荻®(通用名:西达基奥仑赛注射液...
08-28 09:23
8月27日,全球知名生命科学研发与生产服务提供商金斯瑞生物科技股份有限公司(以下简称“金斯瑞”)旗下子公司传奇生物宣布,其自主研发的细胞治疗产品卡卫荻(通用名...
08-27 21:40
传奇生物宣布其自主研发的细胞治疗产品卡卫荻(西达基奥仑赛注射液)获国家药品监督管理局批准上市,用于治疗复发或难治性多发性骨髓瘤成人患者。卡卫荻是一种靶向B细胞成...
08-27 20:49